Infinium Global Research Equine Pharmaceuticals and Supplements Market | Page 10

Equine Pharmaceuticals and Supplements Market: Global Industry Analysis, Trends, Market Size, and,
Forecasts up to 2023
preventing illnesses and for healing the diseases, so that the horses are in good
shape for the races.
Stringent regulations regarding the pharmaceutical products and supplements is a
major restraint for the market. Availability of alternative betting and gambling
avenues affect the equine related industries in matured economies and it is
expected to be a restraint for the growth for global equine pharmaceuticals and
supplements market. Expansion of horse racing in certain geographical regions is
expected to provide opportunities for major players the global equine
pharmaceuticals and supplements market to expand. However, the decrease in
breeding of horses has led to a decrease in population of horses and it is expected
to remain as a major challenge for global equine pharmaceuticals and supplements
market during the forecast period.
The report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. With the presence of 10 million horses
and as one of the horse exporting nations in the world, USA drives the North
American equine pharmaceuticals and supplements market. Some of the key
playe rs in the global Equine Pharmaceuticals and Supplements market are
AFFYMETRIX, Bayer Animal Health, BoehringerIngelheim, CelltrionInc, Elanco
Animal Health, Merck Animal Health, andMerial
GLOBAL EQUINE PHARMACEUTICALS AND SUPPLEMENTS MARKET PROJECTION,
2016 – 2023 (USD MILLION)
2016
10
|
2017
2018
2019
Value
2020
2021
© Infinium Global Research
2022
2023